112 related articles for article (PubMed ID: 3449068)
21. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
Chen YX; Wang SC; Zhao GN; Tang J; Zhang SX; Tang CS
Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
[TBL] [Abstract][Full Text] [Related]
22. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R
Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688
[TBL] [Abstract][Full Text] [Related]
23. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
[TBL] [Abstract][Full Text] [Related]
24. Clinical pharmacokinetics of some newer diuretics.
Beermann B; Grind M
Clin Pharmacokinet; 1987 Oct; 13(4):254-66. PubMed ID: 3311532
[TBL] [Abstract][Full Text] [Related]
25. Plasma adrenomedullin levels in patients with hepatic cirrhosis.
Fábrega E; Casafont F; Crespo J; de la Peña J; San Miguel G; de las Heras G; García-Unzueta MT; Amado JA; Pons-Romero F
Am J Gastroenterol; 1997 Oct; 92(10):1901-4. PubMed ID: 9382062
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and metabolism of theophylline in patients with liver diseases.
Staib AH; Schuppan D; Lissner R; Zilly W; von Bomhard G; Richter E
Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):500-2. PubMed ID: 7203726
[TBL] [Abstract][Full Text] [Related]
27. [Experience in the treatment of diuretic-resistant ascites in liver cirrhosis by intravenous infusion of autogenous ascitic fluid].
Matsuoka K; Ueda Y; Kimura M; Mashiba Y; Kitsuki K
Naika; 1971; 28(1):163-7. PubMed ID: 5565686
[No Abstract] [Full Text] [Related]
28. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
[TBL] [Abstract][Full Text] [Related]
30. [Elimination kinetics of phenprocoumon (Marcumar) in liver cirrhosis and after premedication with phenobarbital].
Heni N; Lehnhardt G; Glogner P
Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):253-61. PubMed ID: 965132
[TBL] [Abstract][Full Text] [Related]
31. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
32. alpha 2-Plasmin inhibitor metabolism in patients with liver cirrhosis.
Knot EA; Drijfhout HR; ten Cate JW; de Jong E; Iburg AH; Kahlé LH; Grijm R
J Lab Clin Med; 1985 Mar; 105(3):353-8. PubMed ID: 3973471
[TBL] [Abstract][Full Text] [Related]
33. Elimination of paracetamol in chronic liver disease.
Arnman R; Olsson R
Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):283-6. PubMed ID: 696204
[TBL] [Abstract][Full Text] [Related]
34. [Relationship of nitric oxide and immunal function of the patients with acute hepatitis and hepatic cirrhosis].
Zhou F; Lu F; Wu H; Lin Q; Lin L
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):379-80. PubMed ID: 12080655
[TBL] [Abstract][Full Text] [Related]
35. Normal metabolism of morphine in cirrhosis.
Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
[TBL] [Abstract][Full Text] [Related]
36. [Chylous ascites in cirrhotic and non-cirrhotic patients].
Casafont F; López-Arias MJ; Crespo J; Dueñas C; Sánchez-Antolín G; Rivero M; Pons Romero F
Gastroenterol Hepatol; 1997; 20(6):291-4. PubMed ID: 9296843
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic value of laboratory examination of ascites fluid (author's transl)].
Wördehoff D
Leber Magen Darm; 1981 Jan; 11(1):25-30. PubMed ID: 6163937
[TBL] [Abstract][Full Text] [Related]
38. Aminoacid imbalance ratio in liver disease.
Maqsood R; Zuberi SJ
J Pak Med Assoc; 1976 Jun; 26(6):145-6. PubMed ID: 826659
[TBL] [Abstract][Full Text] [Related]
39. [Changes in aminophenazone metabolism with acute hepatitis in children (author's transl)].
Windorfer A; Müller G; Stehr C
Dtsch Med Wochenschr; 1977 Oct; 102(41):1460-4. PubMed ID: 913279
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamics and kinetics of etozolin/ozolinone in hypertensive patients with normal and impaired kidney function.
Knauf H; Liebig R; Schollmeyer P; Rosenthal J; Kölle EU; Mutschler E
Eur J Clin Pharmacol; 1984; 26(6):687-93. PubMed ID: 6386484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
